Tritanrix-HepB/Hib-MenAC
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Tritanrix-HepB/Hib-MenAC, covering 2016-09-16 to 2018-09-17. Get the full timeline:
Most recent: Clinical Trial Update: Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m [Phase 3]